Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyssa L Dantonio

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 14, 2021
Intersystem Extrapolation Factors Are Substrate-Dependent for CYP3A4: Impact on Cytochrome P450 Reaction PhenotypingAlyssa L Dantonio, Angela C Doran, R Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 2022
An improved method for cytochrome p450 reaction phenotyping using a sequential qualitative-then-quantitative approachAngela C Doran, Alyssa L Dantonio, Gabrielle M Gualtieri, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 20, 2026
Absorption, distribution, metabolism, and excretion tactics toward the expedited discovery and development of the severe acute respiratory syndrome coronavirus-2 main protease inhibitor nirmatrelvirAmit S Kalgutkar, Heather Eng, Alyssa L Dantonio, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 2022
Defining the Selectivity of Chemical Inhibitors Used for Cytochrome P450 Reaction Phenotyping: Overcoming Selectivity Limitations with a Six-Parameter Inhibition Curve-Fitting ApproachAngela C Doran, Woodrow Burchett, Connor Landers, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2022
Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and HumansHeather Eng, Alyssa L Dantonio, Eugene P Kadar, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 14, 2021
Intersystem Extrapolation Factors Are Substrate-Dependent for CYP3A4: Impact on Cytochrome P450 Reaction PhenotypingAlyssa L Dantonio, Angela C Doran, R Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 2022
An improved method for cytochrome p450 reaction phenotyping using a sequential qualitative-then-quantitative approachAngela C Doran, Alyssa L Dantonio, Gabrielle M Gualtieri, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 20, 2026
Absorption, distribution, metabolism, and excretion tactics toward the expedited discovery and development of the severe acute respiratory syndrome coronavirus-2 main protease inhibitor nirmatrelvirAmit S Kalgutkar, Heather Eng, Alyssa L Dantonio, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 2022
Defining the Selectivity of Chemical Inhibitors Used for Cytochrome P450 Reaction Phenotyping: Overcoming Selectivity Limitations with a Six-Parameter Inhibition Curve-Fitting ApproachAngela C Doran, Woodrow Burchett, Connor Landers, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2022
Disposition of Nirmatrelvir, an Orally Bioavailable Inhibitor of SARS-CoV-2 3C-Like Protease, across Animals and HumansHeather Eng, Alyssa L Dantonio, Eugene P Kadar, et al.
Pageof 1